Onychomycosis in the 21st Century: An Update on Diagnosis, Epidemiology, and Treatment
The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Abstract
Onychomycosis accounts for 50% of all nail disease cases and is commonly caused by dermatophytes. Diabetes, human immunodeficiency virus, immunosuppression, obesity, smoking, and advancing age are predisposing factors of this fungal infection. Potassium hydroxide and culture are considered the current standard for diagnosing onychomycosis, revealing both fungal viability and species identification. Other diagnostic tests currently available include periodic acid–Schiff staining, polymerase chain reaction techniques, and fluorescent staining. Across 6 recently published epidemiology studies, the global prevalence of onychomycosis was estimated to be 5.5%, falling within the range of previously reported estimates (2%-8%). Newly approved onychomycosis treatments include efinaconazole, tavaborole, and laser therapy with lasers only approved to temporarily increase the amount of clear nail. Additional onychomycosis treatments being investigated include iontophoresis and photodynamic therapy with small open-label studies reported thus far. Preventative strategies, to help decrease recurrence and reinfection rates, include sanitisation of footwear and prophylactic topical antifungal agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms of biofilm resistance to antimicrobial agents
Mah, T.-F. C., & O'Toole, G. A. (2001) · Trends in Microbiology · doi:10.1016/s0966-842x(00)01913-2 · Cited by 3,921
Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment
Pfaller, M. A. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.11.001 · Cited by 903
Combination antifungal therapy
Johnson, M. D., MacDougall, C., Ostrosky-Zeichner, L., Perfect, J. R., & Rex, J. H. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.3.693-715.2004 · Cited by 541
Andes, D., Nett, J., Oschel, P., Albrecht, R., Marchillo, K., & Pitula, A. (2004) · Infection and Immunity · doi:10.1128/iai.72.10.6023-6031.2004 · Cited by 389
Gupta, A. K., Jain, H. C., Lynde, C. W., MacDonald, P., Cooper, E. A., & Summerbell, R. C. (2000) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2000.104794 · Cited by 380
Self-citationGupta, Konnikov, Macdonald, Rich, Rodger, Edmonds, Mcmanus, & Summerbell (1998) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1998.02464.x · Cited by 340
Quality of life measurement in dermatology: a practical guide
FINLAY, A. Y. (1997) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1997.5541510.x · Cited by 333
REVIEW ARTICLE: Toenail onychomycosis: an important global disease burden
Thomas, J., Jacobson, G. A., Narkowicz, C. K., Peterson, G. M., Burnet, H., & Sharpe, C. (2010) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2009.01107.x · Cited by 327
Comparison of diagnostic methods in the evaluation of onychomycosis
Weinberg, J. M., Koestenblatt, E. K., Tutrone, W. D., Tishler, H. R., & Najarian, L. (2003) · Journal of the American Academy of Dermatology · doi:10.1067/s0190-9622(03)01480-4 · Cited by 297
Elewski, B. E., Rich, P., Pollak, R., Pariser, D. M., Watanabe, S., Senda, H., Ieda, C., Smith, K., Pillai, R., Ramakrishna, T., et al. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2012.10.013 · Cited by 231
Onychomycosis in clinical practice: factors contributing to recurrence
Scher, R. K., & Baran, R. (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.149.s65.5.x · Cited by 224
Sigurgeirsson, B., Ólafsson, J. H., Steinsson, J. Þ., Paul, C., Billstein, S., & Evans, E. G. V. (2002) · Archives of Dermatology · doi:10.1001/archderm.138.3.353 · Cited by 212
Eradication of Pseudomonas aeruginosa Biofilms by Atmospheric Pressure Non-Thermal Plasma
Alkawareek, M. Y., Algwari, Q. T., Laverty, G., Gorman, S. P., Graham, W. G., O'Connell, D., & Gilmore, B. F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044289 · Cited by 208
A higher prevalence of onychomycosis in psoriatics compared with non-psoriatics: a multicentre study
Gupta, A. K., Lynde, C. W., JAIN, H. C., Sibbald, R. G., Elewski, B. E., Daniel, C. R., Watteel, G. N., & Summerbell, R. C. (1997) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1997.tb03673.x · Cited by 185
Self-citationNew Antifungal Agents and New Formulations Against Dermatophytes
Gupta, A. K., Foley, K. A., & Versteeg, S. G. (2017) · Mycopathologia · doi:10.1007/s11046-016-0045-0 · Cited by 178
Self-citationCandida biofilms: antifungal resistance and emerging therapeutic options.
Kuhn, D. M., & Ghannoum, M. A. (2004) · PubMed · Cited by 170
Elewski, B. E., Aly, R., Baldwin, S. L., González Soto, R. F., Rich, P., Weisfeld, M., Wiltz, H., Zane, L. T., & Pollak, R. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.04.010 · Cited by 164
Gupta, A. K., Lynde, C. W., Jain, H. C., et al. (1997) · PubMed · Cited by 150
Self-citationEffect of onychomycosis on quality of life
Drake, L. A., Scher, R. K., Smith, E. B., Faich, G. A., Smith, S. L., Hong, J. J., & Stiller, M. J. (1998) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(98)70199-9 · Cited by 146
Sotiriou, E., Koussidou-Eremonti, T., Chaidemenos, G., Apalla, Z., & Ioannides, D. (2010) · Acta Dermato Venereologica · doi:10.2340/00015555-0811 · Cited by 143
Treatment options – development of consensus guidelines
Lecha, M., Effendy, I., de Chauvin, M. F., Chiacchio, N. G. D., & Baran, R. (2005) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2005.01284.x · Cited by 141
Diagnosis of Dermatophytosis Using Molecular Biology
Verrier, J., & Monod, M. (2016) · Mycopathologia · doi:10.1007/s11046-016-0038-z · Cited by 130
de Berker, D. (2009) · New England Journal of Medicine · doi:10.1056/nejmcp0804878 · Cited by 115
The role of biofilms in onychomycosis
Gupta, A. K., Daigle, D., & Carviel, J. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.01.008 · Cited by 115
Self-citationSuccessful Treatment of Toenail Onychomycosis With Photodynamic Therapy
Watanabe, D. (2008) · Archives of Dermatology · doi:10.1001/archdermatol.2007.17 · Cited by 113
Lilly, K. K., Koshnick, R. L., Grill, J. P., Khalil, Z. M., Nelson, D. B., & Warshaw, E. M. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.03.033 · Cited by 103
Gupta, A., Gupta, G., Jain, H. C., Lynde, C. W., Foley, K. A., Daigle, D., Cooper, E. A., & Summerbell, R. C. (2016) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13677 · Cited by 103
Self-citationDrug interactions: Proteins, pumps, and P-450s
Shapiro, L. E., & Shear, N. H. (2002) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2002.126823 · Cited by 99
Self-citationThe effect of toenail onychomycosis on patient quality of life
Elewski, B. E. (1997) · International Journal of Dermatology · doi:10.1046/j.1365-4362.1997.00163.x · Cited by 97
The prevalence of culture‐confirmed toenail onychomycosis in at‐risk patient populations
Gupta, A., Daigle, D., & Foley, K. A. (2014) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12873 · Cited by 96
Self-citationThe prevalence of onychomycosis in psoriatic patients: a systematic review
Klaassen, K. M. G., Dulak, M. G., van de Kerkhof, P. C. M., & Pasch, M. C. (2014) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12239 · Cited by 90
New reasons for histopathological nail‐clipping examination in the diagnosis of onychomycosis
Wilsmann‐Theis, D., Sareika, F., Bieber, T. R. M., Schmid-Wendtner, M.-H., & Wenzel, J. (2010) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2010.03704.x · Cited by 89
Histopathological diagnosis of onychomycosis by periodic acid-Schiff-stained nail clippings
Reisberger, E.-M., Abels, C., Landthaler, M., & Szeimies, R. (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2003.05029.x · Cited by 89
Epidemiology and fungal species distribution of superficial mycoses in Northeast Brazil
Rocha, W. P. D. S., de Azevedo, M. F., & Chaves, G. M. (2016) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2016.08.009 · Cited by 83
Ungual and trans-ungual iontophoretic delivery of terbinafine for the treatment of onychomycosis
Nair, A. B., Kim, H. D., Chakraborty, B., Singh, J., Zaman, M., Gupta, A. K., Friden, P. M., & Murthy, S. N. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21711 · Cited by 80
Self-citationGupta, A. K., Konnikov, N., & Lynde, C. W. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.110874 · Cited by 80
Self-citationGilaberte, Y., Aspíroz, C., Martes, M. P., Alcalde, V. M., Espinel‐Ingroff, A., & Rezusta, A. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.06.008 · Cited by 79
Baudraz-Rosselet, F., Ruffieux, C., Lurati, M., Bontems, O., & Monod, M. (2010) · Dermatology · doi:10.1159/000277762 · Cited by 77
Sobell, J. M., Foley, P. J., Toth, D., Mrowietz, U., Girolomoni, G., Gonçalves, J., Day, R. M., Chen, R., & Yosipovitch, G. (2016) · Acta Dermato Venereologica · doi:10.2340/00015555-2360 · Cited by 67
Kondori, N., Abrahamsson, A.-L., Ataollahy, N., & Wennerås, C. (2010) · Medical Mycology · doi:10.3109/13693781003743130 · Cited by 66
DNA repair, immunosuppression, and skin cancer.
Gupta, A. K., & Lynch, L. E. (2004) · PubMed · Cited by 65
Self-citationEpidemiology of onychomycosis in Crete, Greece: a 12‐year study
Maraki, S., & Mavromanolaki, V. E. (2016) · Mycoses · doi:10.1111/myc.12533 · Cited by 62
Hepatitis associated with terbinafine therapy: three case reports and a review of the literature
Gupta, A. K., Rosso, D., Lynde, Brown, & Shear (1998) · Clinical and Experimental Dermatology · doi:10.1046/j.1365-2230.1998.00321.x · Cited by 61
Self-citationNew Insights into Genes, Immunity, and the Occurrence of Dermatophytosis
García‐Romero, M. T., & Arenas, R. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.498 · Cited by 59
Akkuş, G., Evran, M., Güngör, D., Karakaş, M., Tetıker, T., & Sert, M. (2016) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.324.10027 · Cited by 59
Verrier, J., Pronina, M., Peter, C., Bontems, O., Fratti, M., Salamin, K., Schürch, S., Gindro, K., Wolfender, J., Harshman, K., et al. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.05164-11 · Cited by 58
Vila, T. V. M., Rozental, S., & Guimarães, C. M. D. D. S. (2014) · Lasers in Medical Science · doi:10.1007/s10103-014-1689-y · Cited by 58
Mehlig, L., Garve, C., Ritschel, A., Zeiler, A., Brabetz, W., Weber, C., & Bauer, A. (2013) · Mycoses · doi:10.1111/myc.12097 · Cited by 58
Cost-effectiveness of Confirmatory Testing Before Treatment of Onychomycosis
Mikailov, A., Cohen, J. M., Joyce, C., & Mostaghimi, A. (2015) · JAMA Dermatology · doi:10.1001/jamadermatol.2015.4190 · Cited by 58
Comparison of Diagnostic Methods in the Evaluation of Onychomycosis
Haghani, I., Shokohi, T., Hajheydari, Z., Khalilian, A., & Âghili, S. R. (2013) · Mycopathologia · doi:10.1007/s11046-013-9620-9 · Cited by 55
Effect of tunicamycin on Candida albicans biofilm formation and maintenance
Pierce, C. G., Thomas, D. P., & Lopez-Ribot, J. L. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn515 · Cited by 52
Gupta, A., & Nakrieko, K. (2014) · Journal of the American Podiatric Medical Association · doi:10.7547/0003-0538-104.4.330 · Cited by 51
Self-citationEvidence-based optimal fluconazole dosing regimen for onychomycosis treatment
Gupta, A. K., Drummond-Main, C., & Paquet, M. (2012) · Journal of Dermatological Treatment · doi:10.3109/09546634.2012.703308 · Cited by 49
Self-citationGupta, C., Jongman, M., Das, S., Snehaa, K., Bhattacharya, S. N., Seyedmousavi, S., & van Diepeningen, A. D. (2016) · Mycopathologia · doi:10.1007/s11046-016-0014-7 · Cited by 48
Yin, Z., Xu, J., & Luo, D. (2011) · Journal of Dermatological Treatment · doi:10.3109/09546634.2011.579082 · Cited by 46
Epidemiology of onychomycosis in Serbia: a laboratory‐based survey and risk factor identification
Dubljanin, E., Džamić, A., Vujcic, I. S., Grujičić, S. Š., Arsić-Arsenijević, V. S., Mitrović, S., & Čalovski, I. Č. (2016) · Mycoses · doi:10.1111/myc.12537 · Cited by 44
Miyajima, Y., Satoh, K., Uchida, T., Yamada, T., Abe, M., Watanabe, S., Makimura, M., & Makimura, K. (2012) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2012.11.589 · Cited by 42
Novel investigational therapies for onychomycosis: an update
Gupta, A., & Studholme, C. (2016) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2016.1142529 · Cited by 42
Self-citationPetinataud, D., Berger, S., Ferdynus, C., Debourgogne, A., Contet‐Audonneau, N., & Machouart, M. (2016) · Mycoses · doi:10.1111/myc.12471 · Cited by 41
The prevalence of Candida onychomycosis in Southeastern Serbia from 2011 to 2015
Otašević, S., Barac, A. M., Pekmezovic, M. G., Tasic, S., Ignjatović, A., Momčilović, S., Stojanović, P., Arsić-Arsenijević, V. S., & Hay, R. J. (2015) · Mycoses · doi:10.1111/myc.12448 · Cited by 39
GMS is superior to PAS for diagnosis of onychomycosis
D’Hue, Z., Perkins, S. M., & Billings, S. D. (2008) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.2007.00890.x · Cited by 37
Onychomycosis in Israel: epidemiological aspects
Segal, R., Shemer, A., Hochberg, M., Keness, Y., Shvarzman, R., Mandelblat, M., Frenkel, M., & Segal, E. (2015) · Mycoses · doi:10.1111/myc.12287 · Cited by 35
PAS is optimal for diagnosing onychomycosis
Barak, O. G., Asarch, A., & Horn, T. D. (2010) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.2010.01545.x · Cited by 33
Expression of CgCDR1,CgCDR2, and CgERG11 in Candida glabrata biofilms formed by bloodstream isolates
Song, J. W., Shin, J. H., Kee, S. J., Kim, S. H., Shin, M. G., Suh, S. P., & Ryang, D. W. (2009) · Medical Mycology · doi:10.1080/13693780802210726 · Cited by 32
Non‐dermatophytic onychomycosis diagnostic criteria: an unresolved question
Bombace, F., Iovene, M. R., Galdiero, M., Martora, F., Nicoletti, G. F., D’Andrea, M., Pepa, M. E. D., & Vitiello, M. (2016) · Mycoses · doi:10.1111/myc.12504 · Cited by 30
Épidémiologie et prise en charge des onychomycoses en pratique dermatologique libérale en France
Guibal, F., Baran, R., Duhard, E., & de Chauvin, M. F. (2008) · Annales de Dermatologie et de Vénéréologie · doi:10.1016/j.annder.2008.05.004 · Cited by 29
Investigational drugs for onychomycosis
Gupta, A. K., & Simpson, F. C. (2013) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2013.840289 · Cited by 28
Self-citationPolat, M., & ILHAN, M. N. (2015) · PubMed · Cited by 28
Koshnick, R. L., Lilly, K. K., Clair, K. S., Finnegan, M. T., & Warshaw, E. M. (2007) · Mycoses · doi:10.1111/j.1439-0507.2007.01422.x · Cited by 26
KONCPA: A New Method for Diagnosing Tinea unguium
Liu, H. N., Lee, D. D., & Wong, C. K. (2009) · Dermatology · doi:10.1159/000247235 · Cited by 25
Treatment of onychomycosis with efinaconazole 10% topical solution and quality of life.
Tosti, A., & Elewski, B. E. (2014) · PubMed Central · Cited by 21
Review of Treatment for Onychomycosis: Consideration for Special Populations
Barber, K. A., Claveau, J., & Thomas, R. V. R. (2006) · Journal of Cutaneous Medicine and Surgery · doi:10.2310/7750.2006.00054 · Cited by 11
Cited by
Lipner, S. R., & Scher, R. K. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.03.062 · Cited by 345
Onychomycosis: An Updated Review
Leung, A. K. C., Lam, J. M., Leong, K. F., Hon, K. L., Barankin, B., Leung, A. A. M., & Wong, A. H. C. (2020) · Recent Patents on Inflammation & Allergy Drug Discovery · doi:10.2174/1872213x13666191026090713 · Cited by 187
Epidemiology of fungal infections in China
Chen, M., Xu, Y., Hong, N., Yang, Y., Lei, W., Du, L., Zhao, J., Lei, X., Xiong, L., Cai, L., et al. (2018) · Frontiers of Medicine · doi:10.1007/s11684-017-0601-0 · Cited by 137
Pârvu, M., Moţ, C. A., Pârvu, A. E., Mircea, C., Stoeber, L., Roşca-Casian, O., & Ţigu, A. B. (2019) · Molecules · doi:10.3390/molecules24213958 · Cited by 66
“Furthermore, untreated onychomycosis could lead to a secondary infection [20].”
BackgroundEvidence-Based Assessment of the Skin, Hair, and Nails
Gentry, R. D., & Ousley, L. (2024) · Evidence-Based Physical Examination · doi:10.1891/9780826155320.0012
Metadata
- Authors
- Gupta, A. K., Versteeg, S. G., & Shear, N. H.
- Venue
- Journal of Cutaneous Medicine and Surgery
- Publisher
- SAGE Publications
- Published
- 2017-06-22
- Volume
- 21
- Issue
- 6
- Pages
- 525-539
- ISSN
- 1203-4754 (ISSN-L)
- 1615-7109
- OpenAlex
- W2637073256
- Cited by
- 268
- References
- 72
- FWCI
- 13.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.